Literature DB >> 32694760

Oral administration of curcumin ameliorates pulmonary fibrosis in mice through 15d-PGJ2-mediated induction of hepatocyte growth factor in the colon.

Yu-Meng Miao1, Ya-Jing Zhang1, Si-Miao Qiao1, Yu-Feng Xia1, Zhi-Feng Wei2, Yue Dai3.   

Abstract

Oral administration of curcumin has been shown to inhibit pulmonary fibrosis (PF) despite its extremely low bioavailability. In this study, we investigated the mechanisms underlying the anti-PF effect of curcumin in focus on intestinal endocrine. In bleomycin- and SiO2-treated mice, curcumin (75, 150 mg· kg-1 per day) exerted dose-dependent anti-PF effect when administered orally or rectally but not intravenously, implying an intestinal route was involved in the action of curcumin. We speculated that curcumin might promote the generation of gut-derived factors and the latter acted as a mediator subsequently entering the lungs to ameliorate fibrosis. We showed that oral administration of curcumin indeed significantly increased the expression of gut-derived hepatocyte growth factor (HGF) in colon tissues. Furthermore, in bleomycin-treated mice, the upregulated protein level of HGF in lungs by oral curcumin was highly correlated with its anti-PF effect, which was further confirmed by coadministration of c-Met inhibitor SU11274. Curcumin (5-40 μM) dose-dependently increased HGF expression in primary mouse fibroblasts, macrophages, CCD-18Co cells (fibroblast cell line), and RAW264.7 cells (monocyte-macrophage cell line), but not in primary colonic epithelial cells. In CCD-18Co cells and RAW264.7 cells, curcumin dose-dependently activated PPARγ and CREB, whereas PPARγ antagonist GW9662 (1 μM) or cAMP response element (CREB) inhibitor KG-501 (10 μM) significantly decreased the boosting effect of curcumin on HGF expression. Finally, we revealed that curcumin dose-dependently increased the production of 15-deoxy-Δ12, 14-prostaglandin J2 (15d-PGJ2) in CCD-18Co cells and RAW264.7 cells, which was a common upstream of the two transcription factors. Moreover, both the in vitro and in vivo effects of curcumin were diminished by coadministration of HPGDS-inhibitor-1, an inhibitor of 15d-PGJ2 generation. Together, curcumin promotes the expression of HGF in colonic fibroblasts and macrophages by activating PPARγ and CREB via an induction of 15d-PGJ2, and the HGF enters the lungs giving rise to an anti-PF effect.

Entities:  

Keywords:  15d-PGJ2; colon; curcumin; hepatocyte growth factor; intestinal endocrine; pulmonary fibrosis

Mesh:

Substances:

Year:  2020        PMID: 32694760      PMCID: PMC8027789          DOI: 10.1038/s41401-020-0469-4

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  43 in total

1.  Experimental investigation and oral bioavailability enhancement of nano-sized curcumin by using supercritical anti-solvent process.

Authors:  Mohammed Anwar; Iqbal Ahmad; Musarrat H Warsi; Sharmistha Mohapatra; Niyaz Ahmad; Sohail Akhter; Asgar Ali; Farhan J Ahmad
Journal:  Eur J Pharm Biopharm       Date:  2015-08-01       Impact factor: 5.571

2.  In vivo evaluation of curcumin loaded nanosuspensions by oral administration.

Authors:  Yan Gao; Chao Wang; Min Sun; Xin Wang; Aihua Yu; Aiguo Li; Guangxi Zhai
Journal:  J Biomed Nanotechnol       Date:  2012-08       Impact factor: 4.099

3.  Curcumin protects renal tubular epithelial cells from high glucose-induced epithelial-to-mesenchymal transition through Nrf2-mediated upregulation of heme oxygenase-1.

Authors:  Xiuli Zhang; Dan Liang; Lin Guo; Wei Liang; Yan Jiang; Hongjuan Li; Yue Zhao; Shumin Lu; Zhi-Hong Chi
Journal:  Mol Med Rep       Date:  2015-03-27       Impact factor: 2.952

Review 4.  Pathogenesis of idiopathic pulmonary fibrosis.

Authors:  Paul J Wolters; Harold R Collard; Kirk D Jones
Journal:  Annu Rev Pathol       Date:  2013-09-13       Impact factor: 23.472

5.  Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production.

Authors:  C Ireson; S Orr; D J Jones; R Verschoyle; C K Lim; J L Luo; L Howells; S Plummer; R Jukes; M Williams; W P Steward; A Gescher
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

Review 6.  Idiopathic pulmonary fibrosis.

Authors:  Talmadge E King; Annie Pardo; Moisés Selman
Journal:  Lancet       Date:  2011-06-28       Impact factor: 79.321

Review 7.  Hepatocyte growth factor in lung repair and pulmonary fibrosis.

Authors:  Ronald Allan M Panganiban; Regina M Day
Journal:  Acta Pharmacol Sin       Date:  2010-12-06       Impact factor: 6.150

8.  Comparative studies on the suppression of nitric oxide synthase by curcumin and its hydrogenated metabolites through down-regulation of IkappaB kinase and NFkappaB activation in macrophages.

Authors:  M H Pan; S Y Lin-Shiau; J K Lin
Journal:  Biochem Pharmacol       Date:  2000-12-01       Impact factor: 5.858

9.  Curcumin inhibits fibrosis-related effects in IPF fibroblasts and in mice following bleomycin-induced lung injury.

Authors:  Monica R Smith; Srinivasa R Gangireddy; Venkata R Narala; Cory M Hogaboam; Theodore J Standiford; Paul J Christensen; Anand K Kondapi; Raju C Reddy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-01-08       Impact factor: 5.464

10.  Comparative absorption of curcumin formulations.

Authors:  Ralf Jäger; Ryan P Lowery; Allison V Calvanese; Jordan M Joy; Martin Purpura; Jacob M Wilson
Journal:  Nutr J       Date:  2014-01-24       Impact factor: 3.271

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.